Reata Pharmaceuticals, a US-based developer of breakthrough medicines, has secured orphan drug designation from the FDA Office of Orphan Products Development (OOPD) for bardoxolone methyl to treat pulmonary arterial hypertension (PAH).
Continue reading here:
Reata gets FDA orphan drug status for bardoxolone methyl to treat PAH
New Vital Force Technology results show that subtle energy patterns have a significant positive impact on human cell growth. (PRWeb January 13, 2015) Read the full story at http://www.prweb.com/releases/2015/NewSubtleEnergyFindings/prweb12439444.htm
View the original here:
New Subtle Energy Pattern Research Shows Increases in Cell Growth and Viability
CRANBURY, N.J. — Cornerstone Pharmaceuticals, Inc., a development stage company and leader in the growing field of cancer metabolism-based therapeutics, today announced that its lead compound CPI-613 …
See more here:
Cornerstone Pharmaceuticals' CPI-613 Selected as One of Informa and Kantar Health 2014 Top 10 Most Interesting …
CRANBURY, N.J. — Cornerstone Pharmaceuticals, Inc., a development stage company and leader in the growing field of cancer metabolism-based therapeutics, today announced positive data from an ongoing Phase …
CRANBURY, N.J. — Cornerstone Pharmaceuticals, Inc., a clinical stage company and leader in the growing field of cancer metabolism-based therapeutics, today announced the initiation of a Phase I clinical …
BILLERICA, Mass., Oct.
Original post:
Seahorse Bioscience and University of Alabama at Birmingham Partner to Advance Validation of Bioenergetic Health Index …
CRANBURY, N.J. — Cornerstone Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, today announced that data from the Phase I clinical trial evaluating CPI-613 …
View original post here:
Cornerstone Pharmaceuticals' CPI-613 Phase I Hematologic Malignancies Trial Data Published in AACR's Clinical Cancer …
For decades, higher education has often been cast as the villain in the story of U.S. religious decline. Past research supported these claims.
Read the original post:
Study: Higher education doesn't drive people from religion
Researchers at the University of Alabama at Birmingham School of Medicine have created an experimental blood test that, for the first time, determines a “Bioenergetic Health Index,” or BHI, by gauging the performance of mitochondria, the cell's energy powerhouses.
Originally posted here:
Researchers create experimental blood test to determine BHI by gauging performance of mitochondria
Researchers at the UAB School of Medicine have created an experimental blood test that, for the first time, determines a Bioenergetic Health Index, by gauging the performance of mitochondria, the cell's energy powerhouses.
See more here:
New Test Measuring Cell Bioenergetic Health Could Become Key Tool in Personalized Medicine